» Articles » PMID: 11257138

Absence of Monocyte Chemoattractant Protein 1 in Mice Leads to Decreased Local Macrophage Recruitment and Antigen-specific T Helper Cell Type 1 Immune Response in Experimental Autoimmune Encephalomyelitis

Overview
Journal J Exp Med
Date 2001 Mar 21
PMID 11257138
Citations 220
Authors
Affiliations
Soon will be listed here.
Abstract

Monocyte chemoattractant protein (MCP)-1 plays a critical role in innate immunity by directing the migration of monocytes into inflammatory sites. Recent data indicated a function for this chemokine in adaptive immunity as a regulator of T cell commitment to T helper cell type 2 (Th2) effector function. Studies in a Th1-dependent animal model, experimental autoimmune encephalomyelitis (EAE), showed that MCP-1 was highly expressed in the central nervous system (CNS) of affected rodents, and MCP-1 antibodies could block relapses of the disease. Mice deficient for the major MCP-1 receptor, CC chemokine receptor (CCR)2, did not develop EAE after active immunization but generated effector cells that could transfer the disease to naive wild-type recipients. We analyzed EAE in mice deficient for MCP-1 to define the relevant ligand for CCR2, which responds to murine MCP-1, MCP-2, MCP-3, and MCP-5. We found that C57BL/6 MCP-1-null mice were markedly resistant to EAE after active immunization, with drastically impaired recruitment of macrophages to the CNS, yet able to generate effector T cells that transferred severe disease to naive wild-type recipients. By contrast, adoptive transfer of primed T cells from wild-type mice into naive MCP-1-null recipients did not mediate clinical EAE. On the SJL background, disruption of the MCP-1 gene produced a milder EAE phenotype with diminished relapses that mimicked previous findings using anti-MCP-1 antibodies. There was no compensatory upregulation of MCP-2, MCP-3, or MCP-5 in MCP-1-null mice with EAE. These results indicated that MCP-1 is the major CCR2 ligand in mice with EAE, and provided an opportunity to define the role of MCP-1 in EAE. Compared with wild-type littermates, MCP-1-/- mice exhibited reduced expression of interferon gamma in draining lymph node and CNS and increased antigen-specific immunoglobulin G1 antibody production. Taken together, these data demonstrate that MCP-1 is crucial for Th1 immune responses in EAE induction and that macrophage recruitment to the inflamed CNS target organ is required for primed T cells to execute a Th1 effector program in EAE.

Citing Articles

Asking one mechanism in glial cells during neuroinflammation.

Guo X, Harada C, Harada T Neural Regen Res. 2024; 20(4):1077-1078.

PMID: 38989939 PMC: 11438330. DOI: 10.4103/NRR.NRR-D-24-00225.


The brain cytokine orchestra in multiple sclerosis: from neuroinflammation to synaptopathology.

Amoriello R, Memo C, Ballerini L, Ballerini C Mol Brain. 2024; 17(1):4.

PMID: 38263055 PMC: 10807071. DOI: 10.1186/s13041-024-01077-7.


Expression of CD40 and CD192 in Classical Monocytes in Multiple Sclerosis Patients Assessed with Transcranial Magnetic Stimulation.

Rezic Muzinic N, Markotic A, Pavelin S, Polancec D, Buljubasic Soda M, Bralic A Biomedicines. 2023; 11(10).

PMID: 37893243 PMC: 10603866. DOI: 10.3390/biomedicines11102870.


Inhibition of pro-inflammatory signaling in human primary macrophages by enhancing arginase-2 via target site blockers.

Fitzsimons S, Munoz-San Martin M, Nally F, Dillon E, Fashina I, Strowitzki M Mol Ther Nucleic Acids. 2023; 33:941-959.

PMID: 37701067 PMC: 10494319. DOI: 10.1016/j.omtn.2023.08.023.


DAPTA, a C-C Chemokine Receptor 5 (CCR5), Leads to the Downregulation of Notch/NF-κB Signaling and Proinflammatory Mediators in CD40 Cells in Experimental Autoimmune Encephalomyelitis Model in SJL/J Mice.

Alghibiwi H, Ansari M, Nadeem A, Algonaiah M, Attia S, Bakheet S Biomedicines. 2023; 11(6).

PMID: 37371605 PMC: 10294823. DOI: 10.3390/biomedicines11061511.


References
1.
Matsukawa A, Lukacs N, Standiford T, Chensue S, Kunkel S . Adenoviral-mediated overexpression of monocyte chemoattractant protein-1 differentially alters the development of Th1 and Th2 type responses in vivo. J Immunol. 2000; 164(4):1699-704. DOI: 10.4049/jimmunol.164.4.1699. View

2.
Davidson N, Fort M, Muller W, Leach M, Rennick D . Chronic colitis in IL-10-/- mice: insufficient counter regulation of a Th1 response. Int Rev Immunol. 2000; 19(1):91-121. DOI: 10.3109/08830180009048392. View

3.
Gu L, Tseng S, Horner R, Tam C, Loda M, Rollins B . Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature. 2000; 404(6776):407-11. DOI: 10.1038/35006097. View

4.
Sallusto F, Mackay C, Lanzavecchia A . The role of chemokine receptors in primary, effector, and memory immune responses. Annu Rev Immunol. 2000; 18:593-620. DOI: 10.1146/annurev.immunol.18.1.593. View

5.
Zhang S, Lukacs N, Lawless V, Kunkel S, Kaplan M . Cutting edge: differential expression of chemokines in Th1 and Th2 cells is dependent on Stat6 but not Stat4. J Immunol. 2000; 165(1):10-4. DOI: 10.4049/jimmunol.165.1.10. View